Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 61 citations · 31 references
MedicinePharmacologyPharmacotherapyChemotherapyClinical PharmacologyOncology PharmacotherapyAntithrombotic TherapyHematologic Malignancy PharmacotherapyMultiple MyelomaThromboembolism PreventionThrombosisThrombosis PreventionAspirin Prevention TherapyCo-use Of Other DrugsImmunomodulatory EffectsLenalidomide TherapyPharmacologic ThromboprophylaxisThalidomide AnalogsThromboprophylaxis In Cancer PatientsThromboprophylaxis In Medical Inpatients
Multiple myeloma (MM) patients have a propensity for thromboembolic events (TE), and treatment with thalidomide/dexamethasone or lenalidomide/dexamethasone increases this risk. This report describes the use of low-dose aspirin (81 mg) as primary thromboprophylaxis in three series of MM patients receiving thalidomide or lenalidomide with other drugs. In the first regimen (clarithromycin, thalidomide, dexamethasone), initiation of low-dose aspirin negated the occurrence of any further TE. In a second study, prophylactic aspirin given with thalidomide/dexamethasone resulted in a rate of TE similar to that seen with dexamethasone alone (without aspirin). A third study (n = 72) evaluated thrombosis rates with aspirin and a lenalidomide-containing regimen (clarithromycin, lenalidomide, dexamethasone). Of nine occurrences of thromboembolism, five were associated with aspirin interruption or poor compliance. Low-dose aspirin appears to reduce the incidence of thrombosis with these regimens. Routine use of aspirin as antithrombotic prophylaxis in MM patients receiving immunomodulatory drugs with corticosteroids is warranted.
31
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
Alan F. List, Gordon W. Dewald, John M. Bennett et al. · New England Journal of Medicine · 2006 · 1.3K citations
Medicine, Hematology, Pharmacology +17
Nathan Levitan, Afshin Dowlati, Scot C. Remick et al. · Medicine · 1999 · 893 citations
S. Vincent Rajkumar, Emily Blood, David H. Vesole et al. · Journal of Clinical Oncology · 2005 · 874 citations · Full text
Medicine, Hematology, Oncology +13
Antonio Palumbo, Tommaso Caravita, Emanuela Merla et al. · The Lancet · 2006 · 808 citations
Medicine, Oncology, Pharmacology +17